These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24484607)

  • 21. RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling.
    Chaney MO; Stine WB; Kokjohn TA; Kuo YM; Esh C; Rahman A; Luehrs DC; Schmidt AM; Stern D; Yan SD; Roher AE
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):199-205. PubMed ID: 15882940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of secretases by all-trans-retinoic acid.
    Koryakina A; Aeberhard J; Kiefer S; Hamburger M; Küenzi P
    FEBS J; 2009 May; 276(9):2645-55. PubMed ID: 19476501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant presenilin 2 increases β-secretase activity through reactive oxygen species-dependent activation of extracellular signal-regulated kinase.
    Park MH; Choi DY; Jin HW; Yoo HS; Han JY; Oh KW; Han SB; Hwang DY; Hong JT
    J Neuropathol Exp Neurol; 2012 Feb; 71(2):130-9. PubMed ID: 22249458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two β-strands of RAGE participate in the recognition and transport of amyloid-β peptide across the blood brain barrier.
    Kim SJ; Ahn JW; Kim H; Ha HJ; Lee SW; Kim HK; Lee S; Hong HS; Kim YH; Choi CY
    Biochem Biophys Res Commun; 2013 Sep; 439(2):252-7. PubMed ID: 23973487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of Aβ release from human neurons by differentiation status and RET signaling.
    Scholz D; Chernyshova Y; Leist M
    Neurobiol Aging; 2013 Jan; 34(1):184-99. PubMed ID: 22534065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional and post-transcriptional regulation of β-secretase.
    Tamagno E; Guglielmotto M; Monteleone D; Vercelli A; Tabaton M
    IUBMB Life; 2012 Dec; 64(12):943-50. PubMed ID: 23180460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration.
    Chou DK; Zhang J; Smith FI; McCaffery P; Jungalwala FB
    J Neurochem; 2004 Sep; 90(6):1389-401. PubMed ID: 15341523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on Aβ34 biology and detection in transgenic mice brains.
    Caillava C; Ranaldi S; Lauritzen I; Bauer C; Fareh J; Abraham JD; Checler F
    Neurobiol Aging; 2014 Jul; 35(7):1570-81. PubMed ID: 24495834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice.
    Vodopivec I; Galichet A; Knobloch M; Bierhaus A; Heizmann CW; Nitsch RM
    Neurodegener Dis; 2009; 6(5-6):270-80. PubMed ID: 20145420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous secretory receptor for advanced glycation end-products inhibits amyloid-β1-42 uptake into mouse brain.
    Sugihara T; Munesue S; Yamamoto Y; Sakurai S; Akhter N; Kitamura Y; Shiba K; Watanabe T; Yonekura H; Hayashi Y; Hamada J; Yamamoto H
    J Alzheimers Dis; 2012; 28(3):709-20. PubMed ID: 22064071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro amyloid-β binding and inhibition of amyloid-β self-association by therapeutic albumin.
    Milojevic J; Costa M; Ortiz AM; Jorquera JI; Melacini G
    J Alzheimers Dis; 2014; 38(4):753-65. PubMed ID: 24072068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
    Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
    Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular fragment of NLRR3 (NLRR3-ICD) stimulates ATRA-dependent neuroblastoma differentiation.
    Akter J; Takatori A; Islam MS; Nakazawa A; Ozaki T; Nagase H; Nakagawara A
    Biochem Biophys Res Commun; 2014 Oct; 453(1):86-93. PubMed ID: 25256744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity.
    Sturchler E; Galichet A; Weibel M; Leclerc E; Heizmann CW
    J Neurosci; 2008 May; 28(20):5149-58. PubMed ID: 18480271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
    Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic study of the toxic effect of oligomeric Aβ1-42 in situ prepared from 'iso-Aβ1-42'.
    Földi I; Datki ZL; Szabó Z; Bozsó Z; Penke B; Janáky T
    J Neurochem; 2011 May; 117(4):691-702. PubMed ID: 21388376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Osaka FAD mutation E22Δ leads to the formation of a previously unknown type of amyloid β fibrils and modulates Aβ neurotoxicity.
    Ovchinnikova OY; Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
    J Mol Biol; 2011 May; 408(4):780-91. PubMed ID: 21402079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial Alzheimer A2 V mutation reduces the intrinsic disorder and completely changes the free energy landscape of the Aβ1-28 monomer.
    Nguyen PH; Tarus B; Derreumaux P
    J Phys Chem B; 2014 Jan; 118(2):501-10. PubMed ID: 24372615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An improved capillary electrophoresis method for in vitro monitoring of the challenging early steps of Aβ1-42 peptide oligomerization: application to anti-Alzheimer's drug discovery.
    Brinet D; Kaffy J; Oukacine F; Glumm S; Ongeri S; Taverna M
    Electrophoresis; 2014 Dec; 35(23):3302-9. PubMed ID: 25219962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.